Evidence hub

Back Pain & Disc Degeneration: cell-therapy evidence by therapy class

Across every stem-cell intervention, ClinicalTrials.gov holds 35 registered records for Back Pain & Disc Degeneration — 2 recruiting, 2 at Phase 3 or 4, in 11 countries. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The condition, and why cells are proposed

Degenerative disc disease is the usual registry target: dehydrated discs, annular tears and facet loading. Injected cells are proposed to restore disc matrix or damp inflammatory pain signalling. The complication is that imaging findings correlate poorly with pain, so a treatment can change the disc without changing the symptom, and vice versa.

Therapy classes side by side

Therapy classRegisteredRecruitingPhase 3/4Countries
MSC20119
HSCT0000
exosomes1001
PRP5114

Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.

Geography of the research

United States accounts for about 50% of country mentions among sampled studies; 11 countries host at least one site.

CountryStudies with a site there
United States18
South Korea4
Australia3
Italy3
China2
Spain2
Hungary1
Netherlands1

The largest registered studies

Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.

StudyPhaseStatusPlanned nLead sponsorStart
NCT02412735 — Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back PainPhase 3Completed404Mesoblast, Ltd.2015-03-06
NCT00974623 — Bone Graft Materials Observational Registryn/aTerminated329Baxter Healthcare Corporation2009-09
NCT00965380 — Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)n/aCompleted207Orthofix Inc.2009-09
NCT00951938 — Trinity Evolution in Anterior Cervical Disectomy and Fusion (ACDF)n/aCompleted200Orthofix Inc.2009-08
NCT03390920 — Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditionsn/aNot Yet Recruiting200R3 Stem Cell2022-01-01
NCT07338877 — RenewDisc Trial: Endoscopic Discectomy and Autologous Stem Cell Therapy for Discogenic Low Back Painn/aEnrolling By Invitation120EPC Education s.r.o.2024-10-01

Most recently registered

StudyPhaseStatusPlanned nLead sponsorStart
NCT06589271 — SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degenerationn/aSuspendedn/aSclnow Biotechnology Co., Ltd.2026-12-31
NCT07386548 — Biologic Injection For Adults With Lumbar Disc Herniationn/aRecruitingn/aWeill Medical College of Cornell University2026-08-30
NCT04735185 — Stem Cells vs. Steroids for Discogenic Back Painn/aWithdrawnn/aJohns Hopkins University2025-09-30
NCT07338877 — RenewDisc Trial: Endoscopic Discectomy and Autologous Stem Cell Therapy for Discogenic Low Back Painn/aEnrolling By Invitationn/aEPC Education s.r.o.2024-10-01
NCT06490887 — Spine Unit Modelling Coupled With hIgh Throughput Analysis (SUIT)n/aUnknownn/aI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio2023-06-28

Reading this honestly

A registry is a plan repository. Counting entries tells you what people intended to study, which is a weaker thing than what they found. For Back Pain & Disc Degeneration specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.

Frequently asked

How many stem-cell trials exist for Back Pain & Disc Degeneration?

35 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 2 were recruiting.

Which therapy class is furthest along for Back Pain & Disc Degeneration?

Ranked by Phase 3/4 records: MSC (1), PRP (1), HSCT (0), exosomes (0).

Does a recruiting trial mean I can be treated?

No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads

Download the query data

Download CSV · Download JSON

Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.